TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention
After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2....
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2016-11, Vol.68 (18), p.B128-B128 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | B128 |
|---|---|
| container_issue | 18 |
| container_start_page | B128 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 68 |
| creator | Cho, Min Soo Kang, Do-yoon Do, Ungjeong Hong, Jung Ae Lee, Kyusup Kwon, Osung BAE, JAESEOK Kim, Yu Na Lee, Cheol Hyun Kang, Se Hun Yoon, Sung-Han Lee, Pil Hyung Ahn, Jung-Min Park, Duk-Woo Kang, Soo-Jin Lee, Seung-Whan Kim, Young-Hak Lee, Cheol Whan Park, Seong-Wook Park, Seung-Jung |
| description | After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2.15, P = 925), death or myocardial infarction (adjusted HR 0.93, 95% CI 0.46-1.88, P = 0.829) and target vessel failure (adjusted HR 0.96, 95% CI 0.51-1.82, P = 0.902). |
| doi_str_mv | 10.1016/j.jacc.2016.09.441 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1834405596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109716357631</els_id><sourcerecordid>4234728131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1796-2c29a331fd93e017d2b91336aeeb11876e481624d884f9709fa0d6525571cdd13</originalsourceid><addsrcrecordid>eNp9kUGL1TAQx4Mo-Fz9Ap4CnlszTZM0IIKUt7qwsMI-PXgJ2XSqqdlmTdon79ub8hTBg6eZCfP_Z-Y3hLwEVgMD-XqqJ-tc3ZS8ZrpuW3hEdiBEV3Gh1WOyY4qLCphWT8mznCfGmOxA78jp0B8qDkD3R0wx-Ps1V_Qzprxm-iUu9s_bPqyLn7_S2wXnhV7GEOLPrf6Iya2LnTEWQR9TnG060f5bSbyjh-IQ6I1zYc0-zvRqXjAdi0MpnpMnow0ZX_yOF-TT5f7Qf6iub95f9e-uKwdKy6pxjbacwzhojgzU0Nxp4FxaxDuATklsO5BNO3RdO2rF9GjZIEUjhAI3DMAvyKuz70OKP1bMi5nimubypYGOty0TQsvS1Zy7XIo5JxzNQ_L3ZRcDzGyIzWQ2xGZDbJg2BXERvTmLsMx_9JhMdh5nh4NP6BYzRP9_-dt_5C74gs2G73jC_HdMkxvDzO12w-2EILlQkgP_BQkLmg0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834405596</pqid></control><display><type>article</type><title>TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Alma/SFX Local Collection</source><creator>Cho, Min Soo ; Kang, Do-yoon ; Do, Ungjeong ; Hong, Jung Ae ; Lee, Kyusup ; Kwon, Osung ; BAE, JAESEOK ; Kim, Yu Na ; Lee, Cheol Hyun ; Kang, Se Hun ; Yoon, Sung-Han ; Lee, Pil Hyung ; Ahn, Jung-Min ; Park, Duk-Woo ; Kang, Soo-Jin ; Lee, Seung-Whan ; Kim, Young-Hak ; Lee, Cheol Whan ; Park, Seong-Wook ; Park, Seung-Jung</creator><creatorcontrib>Cho, Min Soo ; Kang, Do-yoon ; Do, Ungjeong ; Hong, Jung Ae ; Lee, Kyusup ; Kwon, Osung ; BAE, JAESEOK ; Kim, Yu Na ; Lee, Cheol Hyun ; Kang, Se Hun ; Yoon, Sung-Han ; Lee, Pil Hyung ; Ahn, Jung-Min ; Park, Duk-Woo ; Kang, Soo-Jin ; Lee, Seung-Whan ; Kim, Young-Hak ; Lee, Cheol Whan ; Park, Seong-Wook ; Park, Seung-Jung</creatorcontrib><description>After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2.15, P = 925), death or myocardial infarction (adjusted HR 0.93, 95% CI 0.46-1.88, P = 0.829) and target vessel failure (adjusted HR 0.96, 95% CI 0.51-1.82, P = 0.902).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2016.09.441</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Heart attacks ; Internal Medicine ; Stents</subject><ispartof>Journal of the American College of Cardiology, 2016-11, Vol.68 (18), p.B128-B128</ispartof><rights>2016</rights><rights>Copyright Elsevier Limited Nov 1, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2016.09.441$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids></links><search><creatorcontrib>Cho, Min Soo</creatorcontrib><creatorcontrib>Kang, Do-yoon</creatorcontrib><creatorcontrib>Do, Ungjeong</creatorcontrib><creatorcontrib>Hong, Jung Ae</creatorcontrib><creatorcontrib>Lee, Kyusup</creatorcontrib><creatorcontrib>Kwon, Osung</creatorcontrib><creatorcontrib>BAE, JAESEOK</creatorcontrib><creatorcontrib>Kim, Yu Na</creatorcontrib><creatorcontrib>Lee, Cheol Hyun</creatorcontrib><creatorcontrib>Kang, Se Hun</creatorcontrib><creatorcontrib>Yoon, Sung-Han</creatorcontrib><creatorcontrib>Lee, Pil Hyung</creatorcontrib><creatorcontrib>Ahn, Jung-Min</creatorcontrib><creatorcontrib>Park, Duk-Woo</creatorcontrib><creatorcontrib>Kang, Soo-Jin</creatorcontrib><creatorcontrib>Lee, Seung-Whan</creatorcontrib><creatorcontrib>Kim, Young-Hak</creatorcontrib><creatorcontrib>Lee, Cheol Whan</creatorcontrib><creatorcontrib>Park, Seong-Wook</creatorcontrib><creatorcontrib>Park, Seung-Jung</creatorcontrib><title>TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention</title><title>Journal of the American College of Cardiology</title><description>After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2.15, P = 925), death or myocardial infarction (adjusted HR 0.93, 95% CI 0.46-1.88, P = 0.829) and target vessel failure (adjusted HR 0.96, 95% CI 0.51-1.82, P = 0.902).</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Heart attacks</subject><subject>Internal Medicine</subject><subject>Stents</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kUGL1TAQx4Mo-Fz9Ap4CnlszTZM0IIKUt7qwsMI-PXgJ2XSqqdlmTdon79ub8hTBg6eZCfP_Z-Y3hLwEVgMD-XqqJ-tc3ZS8ZrpuW3hEdiBEV3Gh1WOyY4qLCphWT8mznCfGmOxA78jp0B8qDkD3R0wx-Ps1V_Qzprxm-iUu9s_bPqyLn7_S2wXnhV7GEOLPrf6Iya2LnTEWQR9TnG060f5bSbyjh-IQ6I1zYc0-zvRqXjAdi0MpnpMnow0ZX_yOF-TT5f7Qf6iub95f9e-uKwdKy6pxjbacwzhojgzU0Nxp4FxaxDuATklsO5BNO3RdO2rF9GjZIEUjhAI3DMAvyKuz70OKP1bMi5nimubypYGOty0TQsvS1Zy7XIo5JxzNQ_L3ZRcDzGyIzWQ2xGZDbJg2BXERvTmLsMx_9JhMdh5nh4NP6BYzRP9_-dt_5C74gs2G73jC_HdMkxvDzO12w-2EILlQkgP_BQkLmg0</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Cho, Min Soo</creator><creator>Kang, Do-yoon</creator><creator>Do, Ungjeong</creator><creator>Hong, Jung Ae</creator><creator>Lee, Kyusup</creator><creator>Kwon, Osung</creator><creator>BAE, JAESEOK</creator><creator>Kim, Yu Na</creator><creator>Lee, Cheol Hyun</creator><creator>Kang, Se Hun</creator><creator>Yoon, Sung-Han</creator><creator>Lee, Pil Hyung</creator><creator>Ahn, Jung-Min</creator><creator>Park, Duk-Woo</creator><creator>Kang, Soo-Jin</creator><creator>Lee, Seung-Whan</creator><creator>Kim, Young-Hak</creator><creator>Lee, Cheol Whan</creator><creator>Park, Seong-Wook</creator><creator>Park, Seung-Jung</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20161101</creationdate><title>TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention</title><author>Cho, Min Soo ; Kang, Do-yoon ; Do, Ungjeong ; Hong, Jung Ae ; Lee, Kyusup ; Kwon, Osung ; BAE, JAESEOK ; Kim, Yu Na ; Lee, Cheol Hyun ; Kang, Se Hun ; Yoon, Sung-Han ; Lee, Pil Hyung ; Ahn, Jung-Min ; Park, Duk-Woo ; Kang, Soo-Jin ; Lee, Seung-Whan ; Kim, Young-Hak ; Lee, Cheol Whan ; Park, Seong-Wook ; Park, Seung-Jung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1796-2c29a331fd93e017d2b91336aeeb11876e481624d884f9709fa0d6525571cdd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Heart attacks</topic><topic>Internal Medicine</topic><topic>Stents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cho, Min Soo</creatorcontrib><creatorcontrib>Kang, Do-yoon</creatorcontrib><creatorcontrib>Do, Ungjeong</creatorcontrib><creatorcontrib>Hong, Jung Ae</creatorcontrib><creatorcontrib>Lee, Kyusup</creatorcontrib><creatorcontrib>Kwon, Osung</creatorcontrib><creatorcontrib>BAE, JAESEOK</creatorcontrib><creatorcontrib>Kim, Yu Na</creatorcontrib><creatorcontrib>Lee, Cheol Hyun</creatorcontrib><creatorcontrib>Kang, Se Hun</creatorcontrib><creatorcontrib>Yoon, Sung-Han</creatorcontrib><creatorcontrib>Lee, Pil Hyung</creatorcontrib><creatorcontrib>Ahn, Jung-Min</creatorcontrib><creatorcontrib>Park, Duk-Woo</creatorcontrib><creatorcontrib>Kang, Soo-Jin</creatorcontrib><creatorcontrib>Lee, Seung-Whan</creatorcontrib><creatorcontrib>Kim, Young-Hak</creatorcontrib><creatorcontrib>Lee, Cheol Whan</creatorcontrib><creatorcontrib>Park, Seong-Wook</creatorcontrib><creatorcontrib>Park, Seung-Jung</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cho, Min Soo</au><au>Kang, Do-yoon</au><au>Do, Ungjeong</au><au>Hong, Jung Ae</au><au>Lee, Kyusup</au><au>Kwon, Osung</au><au>BAE, JAESEOK</au><au>Kim, Yu Na</au><au>Lee, Cheol Hyun</au><au>Kang, Se Hun</au><au>Yoon, Sung-Han</au><au>Lee, Pil Hyung</au><au>Ahn, Jung-Min</au><au>Park, Duk-Woo</au><au>Kang, Soo-Jin</au><au>Lee, Seung-Whan</au><au>Kim, Young-Hak</au><au>Lee, Cheol Whan</au><au>Park, Seong-Wook</au><au>Park, Seung-Jung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2016-11-01</date><risdate>2016</risdate><volume>68</volume><issue>18</issue><spage>B128</spage><epage>B128</epage><pages>B128-B128</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>After multivariable adjustment, no significant difference was observed between the two groups in terms of the risk of primary outcome (Hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.59-1.79, P = 0.930 for ZES compared with EES), as well as the risks of death (adjusted HR 0.96, 95% CI 0.43-2.15, P = 925), death or myocardial infarction (adjusted HR 0.93, 95% CI 0.46-1.88, P = 0.829) and target vessel failure (adjusted HR 0.96, 95% CI 0.51-1.82, P = 0.902).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2016.09.441</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2016-11, Vol.68 (18), p.B128-B128 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1834405596 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present); Alma/SFX Local Collection |
| subjects | Cardiology Cardiovascular Heart attacks Internal Medicine Stents |
| title | TCT-311 Everolimus- Versus Zotarolimus-Eluting Stent Following Percutaneous Coronary Chronic Total Occlusion Intervention |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A01%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TCT-311%20Everolimus-%20Versus%20Zotarolimus-Eluting%20Stent%20Following%20Percutaneous%20Coronary%20Chronic%20Total%20Occlusion%20Intervention&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Cho,%20Min%20Soo&rft.date=2016-11-01&rft.volume=68&rft.issue=18&rft.spage=B128&rft.epage=B128&rft.pages=B128-B128&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2016.09.441&rft_dat=%3Cproquest_cross%3E4234728131%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834405596&rft_id=info:pmid/&rft_els_id=S0735109716357631&rfr_iscdi=true |